Hapro Homeo-Chem P Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.80 M
as on 16-11-2024
- Company Age 34 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.80 M
as on 16-11-2024
- Satisfied Charges ₹ 9.58 M
as on 16-11-2024
- Revenue 24.89%
(FY 2023)
- Profit 8.91%
(FY 2023)
- Ebitda 76.54%
(FY 2023)
- Net Worth 11.26%
(FY 2023)
- Total Assets -2.88%
(FY 2023)
About Hapro Homeo-Chem P
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹7.80 M. The company has closed loans amounting to ₹9.58 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Bhushan, Rohan Bhushan, and Mamta Bhushan serve as directors at the Company.
- CIN/LLPIN
U24234MH1990PTC059553
- Company No.
059553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hapro Homeo-Chem P Ltd offer?
Hapro Homeo-Chem P Ltd offers a wide range of products and services, including Ayurvedic Medicine, Ayurvedic Kidney Medicine, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cough Syrup, Cough Medicine, Pharmaceutical Syrup, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Hapro Homeo-Chem P?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Bhushan  | Director | 24-Dec-1990 | Current |
| Rohan Bhushan | Director | 15-Jun-2020 | Current |
| Mamta Bhushan | Director | 25-Aug-2014 | Current |
Financial Performance of Hapro Homeo-Chem P.
Hapro Homeo-Chem P Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 24.89% increase. The company also saw a slight improvement in profitability, with a 8.91% increase in profit. The company's net worth Soared by an impressive increase of 11.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hapro Homeo-Chem P?
In 2023, Hapro Homeo-Chem P had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2021 | ₹7.80 M | Open |
Indian Bank Creation Date: 23 Jul 2004 | ₹1.98 M | Satisfied |
Others Creation Date: 23 Jul 2004 | ₹7.60 M | Satisfied |
How Many Employees Work at Hapro Homeo-Chem P?
Unlock and access historical data on people associated with Hapro Homeo-Chem P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hapro Homeo-Chem P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hapro Homeo-Chem P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
